Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xenon as an adjuvant to sevoflurane anesthesia in children undergoing cardiac catheterization
2014-002510-23Phase 2Completed
- Sponsor
- UZ Leuven
- Start
- Jul 2014
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of xenon in Cardiovascular Malformation (CVM) (2 arms), sponsored by UZ Leuven. Primary endpoint: Feasibility and safety of xenon anesthesia. Started Jul 2014; status: completed.
02
Drugs
xenon
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on 2014-002510-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002510-23.